Topical netarsudil for treatment of glaucoma with elevated episcleral venous pressure: A pilot investigation in sturge-weber syndrome.

Aaron R KaufmanAbdelrahman M ElhusseinyDeepak P EdwardThasarat Sutabutr VajaranantAhmad A ArefJavaneh Abbasian

Published in: European journal of ophthalmology (2023)

Netarsudil can effectively reduce IOP in patients with SWS, even when used as a fourth or fifth glaucoma medication. A possible role for netarsudil in the management of patients with elevated EVP is suggested pending further future investigations.

Keyphrases

optic nerve
healthcare
current status
emergency department
study protocol
case report
randomized controlled trial
adverse drug
smoking cessation